Cannabis use among pregnant and non-pregnant women of childbearing age: Findings from the 2021-2023 National Survey of Drug Use and Health.

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

American Journal of Preventive Medicine Pub Date : 2025-07-02 DOI:10.1016/j.amepre.2025.107967

Timothy J Grigsby, Bertille Assoumou, Stephanie M Koning, Jeffrey T Howard, Krista Howard

{"title":"Cannabis use among pregnant and non-pregnant women of childbearing age: Findings from the 2021-2023 National Survey of Drug Use and Health.","authors":"Timothy J Grigsby, Bertille Assoumou, Stephanie M Koning, Jeffrey T Howard, Krista Howard","doi":"10.1016/j.amepre.2025.107967","DOIUrl":null,"url":null,"abstract":"Introduction: Cannabis use during pregnancy poses potential risks to maternal and neonatal health. This study examines cannabis use prevalence, methods of use (e.g., smoking, vaping, edibles), and associated factors among pregnant and non-pregnant women of reproductive age (12-44 years old) using data from the 2021-2023 National Survey on Drug Use and Health (NSDUH).Methods: Secondary analyses of data from the 2021-2023 NSDUH assessed prevalence of cannabis use and method of use (e.g., smoking, vaping, edibles) along with sociodemographic factors, other substance use, and past year major depressive episode. Multivariable logistic regression models assessed correlates of cannabis use, adjusting for survey design.Results: Cannabis use prevalence was 12.6% among non-pregnant and 6.8% among pregnant women (unweighted N=94,225 women of reproductive age with 2,051 pregnant women). First-trimester use was highest at 10.1%, peaking at 14.2% in 2022. Smoking was the predominant method (non-pregnant: 72.7%; pregnant: 65.4%), followed by vaping and edibles. Covariates of cannabis use included past 30-day alcohol (AOR=7.51; 95% CI=2.71-20.82), tobacco (AOR=3.04; 95% CI=1.50-6.19), and illicit drug use (AOR=4.70; 95% CI=1.37-16.11), and past-year major depressive episode (AOR=2.52; 95% CI=1.35-5.03). Younger age, lower income, and having no children was associated with increased odds of cannabis use.Conclusions: Cannabis use among non-pregnant women increased over the observed period, reflecting increasingly normalized use of cannabis, while pregnant women demonstrated stable rates, with higher first-trimester use. Concurrent substance use and mental health conditions highlight the need for integrated interventions during prenatal care to mitigate risks. These findings underscore the importance of targeted prevention strategies and early interventions, particularly for high-risk groups, to improve maternal and child health outcomes.","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"107967"},"PeriodicalIF":4.3000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amepre.2025.107967","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Cannabis use during pregnancy poses potential risks to maternal and neonatal health. This study examines cannabis use prevalence, methods of use (e.g., smoking, vaping, edibles), and associated factors among pregnant and non-pregnant women of reproductive age (12-44 years old) using data from the 2021-2023 National Survey on Drug Use and Health (NSDUH).

Methods: Secondary analyses of data from the 2021-2023 NSDUH assessed prevalence of cannabis use and method of use (e.g., smoking, vaping, edibles) along with sociodemographic factors, other substance use, and past year major depressive episode. Multivariable logistic regression models assessed correlates of cannabis use, adjusting for survey design.

Results: Cannabis use prevalence was 12.6% among non-pregnant and 6.8% among pregnant women (unweighted N=94,225 women of reproductive age with 2,051 pregnant women). First-trimester use was highest at 10.1%, peaking at 14.2% in 2022. Smoking was the predominant method (non-pregnant: 72.7%; pregnant: 65.4%), followed by vaping and edibles. Covariates of cannabis use included past 30-day alcohol (AOR=7.51; 95% CI=2.71-20.82), tobacco (AOR=3.04; 95% CI=1.50-6.19), and illicit drug use (AOR=4.70; 95% CI=1.37-16.11), and past-year major depressive episode (AOR=2.52; 95% CI=1.35-5.03). Younger age, lower income, and having no children was associated with increased odds of cannabis use.

Conclusions: Cannabis use among non-pregnant women increased over the observed period, reflecting increasingly normalized use of cannabis, while pregnant women demonstrated stable rates, with higher first-trimester use. Concurrent substance use and mental health conditions highlight the need for integrated interventions during prenatal care to mitigate risks. These findings underscore the importance of targeted prevention strategies and early interventions, particularly for high-risk groups, to improve maternal and child health outcomes.

查看原文本刊更多论文

怀孕和非怀孕育龄妇女的大麻使用情况：2021-2023年全国药物使用和健康调查结果。

导言：怀孕期间使用大麻对孕产妇和新生儿健康构成潜在风险。本研究使用2021-2023年全国药物使用和健康调查（NSDUH）的数据，调查了育龄孕妇和非孕妇（12-44岁）的大麻使用情况、使用方法（如吸烟、吸电子烟、食用）和相关因素。方法：对2021-2023年NSDUH的数据进行二次分析，评估大麻使用的流行程度和使用方法（如吸烟、吸电子烟、食用），以及社会人口因素、其他物质使用和过去一年的重度抑郁发作。多变量逻辑回归模型评估了大麻使用的相关因素，并根据调查设计进行了调整。结果：大麻使用率在未怀孕妇女中为12.6%，在怀孕妇女中为6.8%（未加权N=94,225名育龄妇女和2,051名孕妇）。妊娠早期使用率最高，为10.1%，2022年达到14.2%的峰值。吸烟是主要的方法(未怀孕：72.7%；怀孕：65.4%)，其次是电子烟和可食用食品。大麻使用的协变量包括过去30天的酒精(AOR=7.51；95% CI=2.71-20.82)，烟草(AOR=3.04；95% CI=1.50-6.19)和非法药物使用(AOR=4.70；95% CI=1.37-16.11)，过去一年重度抑郁发作(AOR=2.52；95% CI = 1.35 - -5.03)。年龄较小、收入较低、没有孩子与大麻使用几率增加有关。结论：在观察期间，非孕妇的大麻使用率有所增加，反映了大麻使用日益正常化，而孕妇的大麻使用率保持稳定，妊娠早期的大麻使用率较高。同时存在的物质使用和精神健康状况突出表明，需要在产前护理期间采取综合干预措施，以减轻风险。这些调查结果强调了有针对性的预防战略和早期干预的重要性，特别是针对高危群体，以改善孕产妇和儿童的健康结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Preventive Medicine 医学-公共卫生、环境卫生与职业卫生

CiteScore

8.60

自引率

1.80%

发文量

395

审稿时长

32 days

期刊介绍： The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.